See All Slides - tctmd.com

Slides

Presentation TCT 2015

TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

Presenter: Stephen G. Ellis, Lorenz Raber, Patrick W. Serruys

October 13, 2015

Presentation TCT 2015

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

Presenter: Michael A. Weber, Stephen G. Worthley, Elazer R. Edelman

October 13, 2015

Presentation TCT 2015

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Presenter: Sigmund Silber, Philip M. Urban, Evgeny Kretov

October 13, 2015

Presentation TCT 2015

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

Presenter: Gregg W. Stone, Bram D. Zuckerman, Jeffrey Shuren

October 13, 2015

Presentation TCT 2015

TCT 43: Mechanical Abnormalities Associated With Drug-Eluting Stent Thrombosis Analyzed by Optical Coherence Tomography in the National PESTO French Registry

Presenter: Stephan Achenbach, Marc D. Feldman, Nicolas Amabile

October 13, 2015

Presentation TCT 2015

TCT 91: Comparison of Portico and CoreValve Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Surgical Aortic Bioprosthesis Insights From the Valve-in-Valve International Data (VIVID) Registry

Presenter: Jeffrey J. Popma, Mathew Williams, Sami Alnasser

October 13, 2015

Presentation TCT 2015

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

Presenter: Eric Boersma, Richard Smalling, Pieter C. Smits

October 13, 2015

Presentation TCT 2015

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 13, 2015

Presentation TCT 2015

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Freddy Abnousi

October 13, 2015

Presentation TCT 2015

TCT 18: Impact of Incomplete Revascularization After Percutaneous Coronary Intervention as Assessed by the SYNTAX Revascularization Index in Complex Coronary Artery Disease A SEEDS Substudy

Presenter: Eric A. Cohen, Truls Råmunddal, Nicolas Bettingeer

October 13, 2015

Advertisement

Slides

TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology

TCT 43: Mechanical Abnormalities Associated With Drug-Eluting Stent Thrombosis Analyzed by Optical Coherence Tomography in the National PESTO French Registry

TCT 91: Comparison of Portico and CoreValve Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Surgical Aortic Bioprosthesis Insights From the Valve-in-Valve International Data (VIVID) Registry

TCT 1: High Number of Angiographic Significant Lesions Are FFR Negative in STEMI Patients With Multivessel Disease Preliminary Insight Into the COMPARE-ACUTE Trial

My 3 Decades at FDA-CDRH: Historical Perspectives, Landmark Changes, and Major Accomplishments

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

TCT 18: Impact of Incomplete Revascularization After Percutaneous Coronary Intervention as Assessed by the SYNTAX Revascularization Index in Complex Coronary Artery Disease A SEEDS Substudy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content